Omeprazole enteric-coated capsules
Function and Efficacy
Proton pump inhibitor. This product is a fat-soluble weakly alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells and converted into the active form of sulfenamide in this high-acid environment. It then irreversibly combines with the sulfhydryl group of the H,K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons.
Ingredients
Omeprazole.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| OmeprazoleIngredients |
Proton pump inhibitor. This product is a fat-soluble weakly alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells and converted into the active form of sulfenamide in this high-acid environment. It then irreversibly combines with the sulfhydryl group of the H,K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons. More |
73590-58-6 | 83 |
Appearance
Capsules contain small granules in off-white enteric casing.
Indication
It is suitable for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma).
Usage and Dosage
Oral administration, do not chew. 1 Peptic ulcer: 20 mg (1 tablet at a time), 1-2 times a day. Swallow in the morning or once in the morning and evening. The treatment course for gastric ulcer is usually 4-8 weeks, and the treatment course for duodenal ulcer is usually 2-4 weeks. 2 Reflux esophagitis: 20-60 mg (1-3 tablets at a time), 1-2 times a day. Swallow in the morning or once in the morning and evening. The treatment course is usually 4-8 weeks. 3 Zollinger-Ellison syndrome: 60 mg (3 tablets at a time), once a day. The total daily dose can be adjusted to 20-120 mg (1-6 tablets) according to the condition. If the total daily dose exceeds 80 mg (4 tablets), it should be taken in two doses.
Adverse Reactions
Common adverse reactions of this product are: headache, diarrhea, nausea, vomiting, constipation, abdominal pain and bloating. Occasionally, dizziness, drowsiness, fatigue, sleep disorders, paresthesia, rash, itching, urticaria, abnormal liver function tests, etc. are seen. Rarely, hyperhidrosis, peripheral angioedema, hyponatremia; angioedema, fever and anaphylactic shock; leukopenia, thrombocytopenia, agranulocytosis, pancytopenia; reversible mental confusion, irritability, depression, aggression and hallucinations; gynecomastia in men; dry mouth, abnormal taste, stomatitis, candidiasis; hair loss, photosensitivity, erythema multiforme; hepatic encephalopathy (previous severe liver disease), icteric or non-icteric hepatitis, liver failure; bronchospasm; arthralgia, myalgia, muscle fatigue; interstitial nephritis; blurred vision
Precautions
It is contraindicated for patients who are allergic to this product, those with severe renal insufficiency and infants.
Special Population Medication
Precautions for children: It is forbidden for infants and young children. Precautions for pregnancy and lactation: Although this product has no teratogenic effect in animal experiments, it should generally not be used by pregnant women, and should also be used with caution for lactating women. Precautions for the elderly: It is not clear yet.
Drug Interactions
1. Avoid simultaneous use with oral imidazole antifungal drugs such as ketoconazole, itraconazole, miconazole and fluconazole; 2. The combined use of omeprazole and clarithromycin can increase the incidence of adverse reactions of the central nervous system (mainly headache) and gastrointestinal tract; 3. Avoid simultaneous use with diazepam (Valium), phenytoin, warfarin, nifedipine, digoxin, cisapride, quinidine, cyclosporine, caffeine and theophylline; 4. If used with other drugs at the same time, drug interactions may occur. Please consult your doctor or pharmacist for details.
Storage
Keep away from light, sealed and stored in a dry place.
Packaging Specification
20mg
Validity Period
24 months.
Manufacturer
Shanxi Jinhuahuixing Pharmaceutical. Co., Ltd.
-
Founded in:
2004-04-23 -
Address:
No. 8 Fengxiang Road, Qingjian Street, Hejin City, Yuncheng City, Shanxi Province -
Tax NO.:
911408007572846589 -
Registered Funds:
33.6 million yuan -
Website:
-
Email: